In-Vitro Fertilization Market Size, Share, AI Trends & Forecast 2026 to 2035

Revenue, 2025

USD 32.11 Bn

Forecast Year, 2035

USD 73.09 Bn

CAGR, 2026 - 2035

8.57%

Report Coverage

Global

What is the In-Vitro Fertilization Market Size?

The global in-vitro fertilization market size was estimated at USD 32.11 billion in 2025 and is predicted to increase from USD 34.97 billion in 2026 to approximately USD 73.09 billion by 2035, expanding at a CAGR of 8.57% from 2026 to 2035. The market is driven by the increasing number of infertile cases, and advanced techniques in Reproductive Assisted Technologies (RATs) are the major factors for market growth.

In-Vitro Fertilization Market Key Takeaways

• Europe dominated the global in-vitro fertilization market with the largest market share of 38% in 2025.
• Asia Pacific is projected to expand at the fastest CAGR during the forecast period.
• By procedure type, the frozen non-donor segment contributed the highest market share in 2025.
• By instruments, the culture media segment captured the biggest market share in 2025.
• By end user, the fertility clinics segment has held the largest market share in 2025.

Market Overview

The in-vitro fertilization market is growing due to rising infertility cases, higher awareness of reproductive technologies, and the widespread acceptance of fertility treatment by couples and individuals. IVF treatments provide high success rates because of the advancement of technology in embryo culture, genetic testing, and cryopreservation. Factors such as enhanced healthcare facilities, initiatives undertaken by governments regarding fertility programs, and medical tourism are other driving factors for the growth of the market. Delayed pregnancy, infertility due to lifestyle, and ongoing research in reproductive medicine are some of the upcoming trends.

Artificial intelligence: The New Precision in IVF

Artificial intelligence is bringing a wave of change to in vitro fertilization, making it more precise, with higher eventualities of success and efficiency. An algorithm acting on AI converts data, both from images and biological sources, to select embryos with the maximum possible potential for implantation, excluding chance, if not pure trial-and-error procedures. It customizes treatment regimens by amalgamating hundreds of parameters from medical histories, hormone levels, and lifestyle factors. AI, meanwhile, rids repetitive activities and lays down standardized operational protocols to deliver increased consistency and the resultant slight errors. Predictive analysis aids physicians in diagnosing complications early and adjusting treatment protocols accordingly. Innovation is, thus, expedited for a future that is reliable, effective, and patient-centered within the ambit of IVF treatments.

In-Vitro Fertilization Market Growth Factors

• A steady rise in the incidence of male infertility is causing a growing demand for ART.
• The growing median age of first-time mothers is due to lifestyle modifications and career priority-induced upward push into IVF treatments.
• The increased trend of delayed pregnancies has increased infertility risks and, consequently, should demand for IVF answers.
• Declining fertility rates with other populations are proving to grow market opportunities significantly.
• Growing awareness of infertility and availability of advanced treatment options have almost led IVF to universal acceptance.
• Rising infertility rates: The combination of factors such as stress, pollution, hormonal imbalance, and change in lifestyle is responsible for the rise of male and female infertility, which in turn is a major contributor to the demand for IVF.
• Delayed parenthood trends: Couples who are more concerned with their professional career and personal goals are the ones to experience a postponement of marriage and childbirth, which then results in age-related fertility problems and infertility treatment cycles.
• Declining fertility rates: The world has already seen a huge drop in the number of sperm and in the rates of natural conception, which has drastically increased the need for IVF technology.
• Technological advancements: Technologies like cryopreservation, time-lapse embryo imaging, and better culture media are making the process of IVF more successful as well as more accessible.
• Growing awareness and acceptance: The awareness campaigns that are becoming more common, the regulations that are getting more favorable, and the stigma that is shrinking surrounding infertility treatments are the factors behind the global embracement of IVF.

Market Outlook

• Industry Growth Overview: The rising median age of first-time mothers is a significant growth driver. This is attributed to the rising number of women in the population prioritizing their education, work, and career. This results in late marriages.
• Global Expansion: Europe and North America currently hold the largest market shares in terms of revenue, while the Asia-Pacific region is expected to be the fastest-growing market.
• Major investors: Major companies and investors in the market include large corporations like CooperSurgical, Merck, Vitrolife, and Fujifilm.
• Startup Ecosystem: The In-Vitro Fertilization (IVF) startup ecosystem is witnessing rapid growth, fuelled by technological innovations such as Artificial Intelligence (AI), advanced genetic testing, and telehealth platforms.

In-Vitro Fertilization Market Trends

• Stem Cell Treatment: Stem cells have become a trend in the IVF industry as researchers are discovering their capability to develop pregnancy and fertility results. Stem cells are unclassified cells that have the potential to develop into any kind of cell in the body. They have the capacity to repair an toxic tissue and make new cells, which makes them a promising option for diagnosing a huge range of conditions.
• Cryopreservation: Fertility cryopreservation is a procedure to protect fertility if a person's reproductive health is affected due to medical conditions. This procedure counters freezing biological tissues like as sperm,eggs and embryos for further application.
• Laser Assisted Hatching: One of the main demands in IVF is developing the application of assisted hatching, as the procedure involves making a minute hole in the outer layer of the embryo to assist with implantation and hatching in the uterus.
• Embryoscope (Time Lapse Imaging): Embryoscopes are developing as another exciting demand in IVF diagnosis. Time-lapse imaging enables doctors to manage the growth of embryos in real time and choose the most eligible ones for transfer.
• Preimplantation Genetic Screening: Preimplantation genetic diagnosis (PGD) and genetic screening involve testing embryos for genetic abnormalities even before they are transferred to the uterus for implantation. This can help improve the chances of successful pregnancy and lower the risk of miscarriage.

Market Report Coverage and Key Metrics

Market Dynamics

Driver

Rising Infertility Rates and Delayed Parenthood

The growing incidence of infertility due to changes in lifestyle, obesity, stress, hormonal problems, and delay in having children is another important factor behind the growth of the IVF market. Increasingly, people are opting to have babies later in their lives, and hence, there is an increasing requirement for techniques to aid fertility. The growing knowledge about fertility treatments, the growing number of fertility clinics, and the improving success rate of IVF are some more factors contributing to market growth.

Restraint

High Treatment Costs and Limited Insurance Coverage

The high price of IVF treatments is another issue facing the market's growth, particularly in developing nations. The costs of several IVF cycles, tests, fertility drugs, and embryo freezing add up to make the total cost of the treatment more expensive. Lack of insurance coverage and differential accessibility to fertility treatment facilities make people refrain from using the treatment.

Opportunity

AI Integration and Fertility Preservation

The use of AI, high-end embryo imaging, and genetic screening technologies is opening up lucrative avenues for the IVF market. The application of artificial intelligence for embryo selection enhances the precision of treatments and pregnancy rates. The rising number of people opting for fertility preservation due to cancer and deferred conception provides an additional scope for the market. The increasing investment in reproductive medicine and fertility clinics, along with medical tourism in developing nations, is likely to create market avenues for players.

Market Segmentation Analysis

Product Type Insights

Based on the product type, the fresh non-donor segment dominated the market with revenue share in 2025. This is attributable to various factors such as high rate of success, higher birth rates as compared to that of frozen embryos, easy implantation, and the fresh embryo transfer results in better results. The higher adoption of the fresh non-donor cycle coupled with the rising infertility rates across the globe is the major driver of this segment. The increased popularity of this cycle is expected to sustain its dominance throughout the forecast period.

The frozen non-donor is expected to witness fastest growth segment during the forecast period. This is mainly attributed to the higher pregnancy rates along with the low cost. Frozen transfer is much easier for both the patients and the endocrinologists. Moreover, the level of stress on the physical and mental health of the women is less in the frozen non-donor cycle, which is expected of fuel the growth of this segment in the forthcoming years.

End User Insights

Based on the end user, the fertility clinics segment accounted largest revenue share in 2025. Fertility clinics are the first preference for the couples to diagnose their issues related with fertility. The fertility clinics are the specialized clinics that offers specialized care services to the couples and individuals related to their pregnancy and fertility problems. The increasing number of fertility clinics, increasing awareness regarding the fertility clinics, and declining fertility rates are the major factors that has fostered the growth of the fertility clinics segment across the globe.

Hospitals is estimated to be the most opportunistic segment during the forecast period. The wide spread penetration of the hospitals, developing healthcare infrastructure in developing nations, 24*7 presence of health professionals, and availability of advanced surgical tools and equipment in hospitals are the major factors that boosts the demand for the hospital services.

Market Regional Analysis: North America, Europe, Asia-Pacific

Europe In-Vitro Fertilization Market Size and Growth 2026 to 2035

The Europe in-vitro fertilization market size was evaluated at USD 12.20 billion in 2025 and is predicted to be worth around USD 28.23 billion by 2035, rising at a CAGR of 8.75% from 2026 to 2035.

Europe dominated the global market with the largest market share of 38% in 2025. due to rising medical tourism and legal revisions related to IVF techniques.

Asia Pacific region is expected to witness remarkable CAGR during the forecast period. This is attributed to the presence of huge population, rapidly declining fertility rates, rising number of women focused government initiatives, growing preference for careers over family among women population, and increased awareness regarding the fertility clinics and procedures. The growing awareness among the population regarding the in-vitro fertilization, rising healthcare expenditure, and rising adoption of advanced reproductive technology in Asia Pacific are the prominent drivers of the in-vitro fertilization market. Furthermore, the rising medical tourism industry is anticipated to impact the growth of the in-vitro fertilization market in the region. The country like Japan and South Korea are facing declining rate of population owing to the rising median age of the first time mothers. Women in these countries are more concerned regarding their career and gives lesser importance over starting a family during their 20s. Therefore this results in delayed marriages and delayed pregnancies. Women over the age of 35 years have higher chances of miscarriage and stillbirth. Therefore, sometimes even after receiving the fertility treatment, the success rate is low due to the aging factor of the women. This factor may have negative impact on the market especially in countries like South Korea and Japan. Moreover, the population control policies of the Chinese government is expected to have a massive impact on the China in-vitro fertilization market.

How Europe Dominated the In-Vitro Fertilization Market?

Europe dominated the market in 2025 because of its favorable healthcare policies, increased awareness regarding infertility, and extensive clinical research. Funding by governments of certain nations, advanced laboratories for fertility, and the widespread use of genetic testing help fuel the market growth. Increased age of mothers and technological advances in reproductive medicine also contribute to the market growth.

Germany Market Trends

The German market is driven by the presence of well-developed fertility centers and growing demand for fertility treatment procedures. The country makes use of the latest laboratory equipment and embryology methods. High rates of infertility help promote further development of the market.

What are the Key Trends of the In-Vitro Fertilization Market in Asia-Pacific?

Asia-Pacific is expected to experience the fastest growth during the predicted timeframe, owing to an increase in infertility cases, healthcare investment, growth in the number of fertility clinics, and government initiatives. Medical tourism, healthcare infrastructure development, and disposable income boost the use of IVF technology.

China Market Trends

There is rapid growth in China due to increased provision of fertility services due to favorable childbirth policies and investments in reproductive health care. Increased incidences of infertility, urbanization, and improved access to IVF technologies have led to high market demand in the country.

How is North America Growing in the In-Vitro Fertilization Market?

North America is expected to grow at a notable CAGR in the foreseeable future, due to the presence of advanced healthcare infrastructure, higher awareness regarding fertility treatments, and a higher penetration rate of reproductive technology. Some of the factors that are driving the North American market include continual advances in technology, an aging population, expansion of fertility clinics, and investment in reproductive medicine.

U.S. Market Trends

The U.S. leads the regional market with an abundance of fertility centers, highly advanced techniques for IVF, and an increasing number of infertility treatments. Delayed pregnancies, increased acceptance of assisted reproduction, and increasing application of AI technology in embryo selection are factors that further boost demand in the country's market.

Why is Latin America Growing Significantly in the In-Vitro Fertilization Market?

Latin America is considered to be a significantly growing area, due to the development of health care infrastructure, higher awareness about fertility procedures, and an increased number of private fertility clinics. Higher number of infertility cases, medical tourism, and easy access to reproductive health care stimulate the market growth.

Brazil Market Trends

Brazil is the market leader in this regard due to an increasing number of fertility clinics and increased acceptance of ARTs. Increased healthcare spending, late marriages, and an increase in private healthcare provision will keep supporting the demand for IVF treatments.

Will the Middle East and Africa Grow in the In-Vitro Fertilization Market?

The Middle East and Africa are expected to grow at a considerable CAGR in the upcoming period. In addition to increased expenditure in healthcare, improved healthcare facilities for infertility and heightened awareness of infertility are among the factors contributing to the expansion of the market in the Middle East & Africa region. Investments in specialized reproductive facilities are other contributors to the development of the market in the region.

Saudi Arabia Market Trends

There is an increased demand for IVF treatments in Saudi Arabia driven by high infertility rates, the emergence of private fertility clinics, and health care investments. Reproductive technology advancement is still ongoing in the country, together with access to fertility treatment services.

In-Vitro Fertilization Market Value Cain Analysis

• R&D: New IVF systems are being invented to increase success rates; hence, we have AI to perform embryo assessment. Similarly, research can be zones for improvements in genetic screening and culture media.
  Key Players: Illumina Inc., Thermo Fisher Scientific
• Clinical Trials and Regulatory Approvals: At this stage, the new protocols, technologies, and drugs of IVF are converted to undergo human test of safety and efficacy testing, and the authorities enforce the issuance of licenses for their use.
  Key Players: U.S. Food and Drug Administration, Boston IVF, and Nova IVF Fertility
• Formulation and Final Dosage Preparation: In IVF, this refers to special media preparation for embryo culture and cryopreservation, and preparing hormonal medicines for ovarian stimulation, such as gonadotropins and GnRH-analogs.
  Key Players: Merck KGaA, Fujifilm Irvine Scientific
• Serialization and Packaging: Packing of specialized media, medicines, and other IVF products shall be undertaken, keeping in mind the regulations about labeling, serialization to ensure traceability, and authentication in the pharmaceutical supply chain.
  Key Players: McKesson, Vitrolife, and CooperSurgical
• Distribution to Hospitals, Pharmacies: It is the logistics of transporting packaged IVF products and medications from manufacturers to fertility clinics.
  Key Players: FedEx and UPS

Market Competitive Landscape: Leading Companies and Strategies

The in-vitro fertilization market is partially consolidated and includes companies providing global medical technology, fertility services, and those that manufacture the IVF products. The presence of established competitors will definitely help them due to a high level of brand awareness, laboratory technology, and extensive distribution channels. It is quite difficult for new entrants to enter the market due to the presence of various entry barriers.

Major players in the market include CooperSurgical, Vitrolife AB, Merck KGaA, FUJIFILM Irvine Scientific, Cook Medical, and Thermo Fisher Scientific. These firms consolidate their market position by launching new products, forming strategic alliances, making acquisitions, and investing in R&D. Embryo selection via artificial intelligence, time-lapse monitoring, advanced culture media, and genetic testing technologies are now among the major competitive advantages. With increasing demand for fertility services globally, it is anticipated that competition will further escalate over the forecast period.

In-Vitro Fertilization Market Key Players' Offering

• CooperSurgical Inc. (US): This company provides a diverse range of products and services for reproductive health professionals.
• Cook Medical Inc. (US): A leader in IVF care, Cook Medical offers specialized tools and technologies to manage various aspects of the IVF process.
• Thermo Fisher Scientific (US): Thermo Fisher provides detailed solutions to fertility clinics, including a wide array of laboratory equipment such as CO2 incubators.

Other In-Vitro Fertilization Market Companies

• AmbroiseParé Group
• Amedes MVZ Cologne GmbH
• AMP Center St Roch
• AVA Clinic Scanfert
• Bangkok IVF center
• Betamedics
• Biofertility Center
• Bloom Fertility and Healthcare
• Bloom Fertility Center
• Bourn Hall Fertility Center

Key Market Developments

• In January 2021, Merck KGaA and Royal Philips entered into a partnership for the development of digital solution for providing personalized treatment for fertility.
• In January 2020, Merck KGaA acquired the market authorization for its GONALI-f pen from the European Commission.
• In 2020, Fujifilm Irvine Scientific launched a vitrification media solution named Vit Kit-NX.
• In 2020, Genea Ltd. Hamilton Throne Ltd. collaborated to commercialize fertility products of Genea Ltd. in North America.

Recent Developments

• In July 2026, Gaudium IVF and Women Health Limited officially disclosed its AI-linked Signature Labs to begin its planned 19-centre national growth, which matches the beginning of clinical operations at its current hub in South Extension. (Source: https://www.sahi.com)
• In April 2026, EIR Forsakring and Onuava revealed Fertility +, which is a corporate health insurance product for the German industry that concentrates on family and fertility construction. The services have safeguarded diagnoses such as ICSI, IVF, social egg freezing, and insemination that have employer-funded subsidies of euro 3,000-euro 5,00 or up to euro 10,000 depending on the strategy. (Source: https://coverager.com)
• In March 2026, Wockhardt Hospitals, Mumbai-Central has revealed that a focused Mother & Child Care Unit named Miracle is being crafted to develop fertility services, tailored neonatal intensive care and pregnancy tracking for families present across Mumbai Metropolitan Region (MMR). (Source: https://theindianpractitioner.com)
• In December 2025, Intas Pharmaceuticals, a top multinational pharmaceutical brand, entered into a current agreement with Integrimedicall, as this technology leader at the back of India's primary Needle-Free Injection System (N-FIS) has revealed such updated technology for application in gynecology diagnosis and IVF across India. (Source: https://www.expresshealthcare.in)
• In February 2026, KEM Hospital launched the MAA IVF Centre that is a technologically advanced fertility center established through a collaborative effort between the government and private sector to provide cost-effective IVF treatment. (Source: https://theindianpractitioner.com)
• In January 2026, Aksigen IVF launched the Bharat Daftary Knowledge Centre in Mumbai, India's first immersion IVF training center, aimed at improving awareness among patients through hands-on learning and providing scientific information on fertility treatments and IVF procedures. (Source: https://health.economictimes.indiatimes.com)
• In September 2025, Overture Life launched a European preorder waitlist for DaVitri, the world's first automated vitrification platform, aiming to reduce manual workloads and eliminate operator variability in IVF facilities. (Source: https://www.businesswire.com)
• In July 2025, Apollo Fertility launched a campaign, #GuessTheIVFBaby, to challenge public misconceptions about fertility and assisted reproduction, focusing on the question of who truly knows an IVF baby. (Source: https://www.expresshealthcare.in)

Segments Covered in the Report

By Product Type

• Fresh Donor
• Fresh Non-Donor
• Frozen Donor
• Frozen Non-Donor

By End User

• Fertility Clinics
• Surgical Centers
• Hospitals
• Research Institutes

By Product

• Equipment
  • Sperm Analyzer Systems
  • Imaging Systems
  • Ovum Aspiration Pumps
  • Micromanipulator Systems
  • Incubators
  • Gas Analyzers
  • Laser Systems
  • Cryosystems
  • Sperm Separation Devices
  • IVF Cabinets
  • Anti-vibration Tables
  • Witness Systems
  • Other Equipments
• Reagents & Media
  • Cryopreservation Media
  • Embryo Culture Media
  • Ovum Processing Media
  • Sperm Processing Media
• Accessories

By Type

• Conventional IVF
• IVF with ICSI
• IVF with Donar Eggs
• Others

By Instrument

• Culture Media
• Disposable Devices
• Capital Equipment

By Region

• North America
• Latin America
• Europe
• Asia-pacific
• Middle and East Africa